| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telomere | 77 | 2024 | 943 | 8.610 |
Why?
|
| Endometrial Neoplasms | 66 | 2025 | 1378 | 8.430 |
Why?
|
| Leukocytes | 51 | 2024 | 2027 | 4.590 |
Why?
|
| Genetic Predisposition to Disease | 80 | 2023 | 18071 | 1.790 |
Why?
|
| Polymorphism, Genetic | 34 | 2015 | 4247 | 1.750 |
Why?
|
| Polymorphism, Single Nucleotide | 77 | 2024 | 16047 | 1.520 |
Why?
|
| Genome-Wide Association Study | 48 | 2024 | 12807 | 1.350 |
Why?
|
| Case-Control Studies | 108 | 2025 | 22223 | 1.320 |
Why?
|
| Telomerase | 10 | 2023 | 749 | 1.240 |
Why?
|
| DNA, Mitochondrial | 11 | 2023 | 869 | 1.120 |
Why?
|
| Aging | 26 | 2024 | 8731 | 1.040 |
Why?
|
| Receptors, Progesterone | 6 | 2017 | 1153 | 0.980 |
Why?
|
| Nurses | 19 | 2017 | 2505 | 0.910 |
Why?
|
| Urinary Bladder Neoplasms | 16 | 2023 | 2176 | 0.870 |
Why?
|
| Body Mass Index | 27 | 2025 | 13039 | 0.820 |
Why?
|
| DNA Copy Number Variations | 11 | 2023 | 2045 | 0.810 |
Why?
|
| Genotype | 53 | 2024 | 13024 | 0.810 |
Why?
|
| Adenocarcinoma | 10 | 2016 | 6364 | 0.780 |
Why?
|
| Risk Factors | 113 | 2025 | 74840 | 0.740 |
Why?
|
| Middle Aged | 176 | 2025 | 223009 | 0.730 |
Why?
|
| Glutathione Transferase | 5 | 2011 | 562 | 0.700 |
Why?
|
| Female | 235 | 2025 | 396112 | 0.700 |
Why?
|
| Ovarian Neoplasms | 16 | 2023 | 4900 | 0.700 |
Why?
|
| Alleles | 30 | 2021 | 6897 | 0.660 |
Why?
|
| Glucuronosyltransferase | 5 | 2012 | 136 | 0.660 |
Why?
|
| Carbon | 2 | 2013 | 677 | 0.640 |
Why?
|
| Estradiol | 9 | 2012 | 1947 | 0.620 |
Why?
|
| DNA Methylation | 15 | 2024 | 4424 | 0.620 |
Why?
|
| Humans | 294 | 2025 | 765968 | 0.600 |
Why?
|
| Genetic Loci | 10 | 2017 | 2631 | 0.590 |
Why?
|
| Genetic Variation | 18 | 2021 | 6610 | 0.570 |
Why?
|
| Coffee | 3 | 2020 | 593 | 0.570 |
Why?
|
| Adult | 142 | 2025 | 223044 | 0.570 |
Why?
|
| Arylamine N-Acetyltransferase | 4 | 2023 | 87 | 0.560 |
Why?
|
| Smoking | 25 | 2025 | 9081 | 0.550 |
Why?
|
| Postmenopause | 8 | 2012 | 2515 | 0.550 |
Why?
|
| Vitamin D | 4 | 2015 | 3272 | 0.540 |
Why?
|
| Diet | 14 | 2023 | 8086 | 0.540 |
Why?
|
| Aromatase | 6 | 2009 | 147 | 0.500 |
Why?
|
| Prospective Studies | 69 | 2023 | 54802 | 0.490 |
Why?
|
| Diet, Mediterranean | 3 | 2020 | 746 | 0.490 |
Why?
|
| Paternal Age | 2 | 2012 | 87 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 360 | 0.480 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 5 | 2008 | 246 | 0.480 |
Why?
|
| Haplotypes | 12 | 2014 | 2728 | 0.450 |
Why?
|
| Aged | 99 | 2025 | 171117 | 0.450 |
Why?
|
| Menarche | 4 | 2025 | 532 | 0.440 |
Why?
|
| Skin Neoplasms | 13 | 2020 | 5849 | 0.430 |
Why?
|
| Gene Frequency | 13 | 2024 | 3624 | 0.430 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2017 | 798 | 0.420 |
Why?
|
| Phobic Disorders | 3 | 2018 | 440 | 0.420 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2012 | 558 | 0.410 |
Why?
|
| Talc | 2 | 2010 | 48 | 0.410 |
Why?
|
| Carcinoma, Basal Cell | 6 | 2016 | 566 | 0.410 |
Why?
|
| Breast Neoplasms | 22 | 2015 | 21056 | 0.400 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2004 | 251 | 0.390 |
Why?
|
| Caffeine | 5 | 2020 | 702 | 0.380 |
Why?
|
| Risk | 19 | 2024 | 9591 | 0.370 |
Why?
|
| Social Class | 4 | 2023 | 2007 | 0.370 |
Why?
|
| Endometriosis | 4 | 2023 | 870 | 0.370 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2010 | 16 | 0.370 |
Why?
|
| Cohort Studies | 47 | 2024 | 41649 | 0.360 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2010 | 58 | 0.360 |
Why?
|
| Arthritis, Rheumatoid | 6 | 2016 | 3733 | 0.360 |
Why?
|
| Life Change Events | 3 | 2024 | 954 | 0.360 |
Why?
|
| Hydro-Lyases | 1 | 2010 | 93 | 0.350 |
Why?
|
| Vitamin B Complex | 1 | 2013 | 299 | 0.350 |
Why?
|
| Cross-Sectional Studies | 24 | 2024 | 26318 | 0.350 |
Why?
|
| Estrone | 6 | 2010 | 234 | 0.350 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2011 | 125 | 0.350 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2010 | 28 | 0.340 |
Why?
|
| Polymerase Chain Reaction | 15 | 2016 | 6069 | 0.340 |
Why?
|
| Menopause | 9 | 2024 | 1659 | 0.340 |
Why?
|
| Body Height | 3 | 2023 | 1562 | 0.330 |
Why?
|
| Puberty | 3 | 2024 | 491 | 0.330 |
Why?
|
| Reproduction | 3 | 2015 | 641 | 0.330 |
Why?
|
| Obesity | 14 | 2023 | 13076 | 0.330 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2011 | 271 | 0.320 |
Why?
|
| Life Style | 8 | 2021 | 3926 | 0.320 |
Why?
|
| Leiomyoma | 3 | 2010 | 643 | 0.310 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2011 | 416 | 0.310 |
Why?
|
| Epigenesis, Genetic | 8 | 2024 | 3819 | 0.310 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2010 | 1206 | 0.310 |
Why?
|
| Logistic Models | 23 | 2023 | 13266 | 0.310 |
Why?
|
| Temperament | 2 | 2023 | 299 | 0.310 |
Why?
|
| Perineum | 1 | 2010 | 213 | 0.310 |
Why?
|
| Antioxidants | 5 | 2021 | 1670 | 0.310 |
Why?
|
| Hyperinsulinism | 2 | 2023 | 402 | 0.310 |
Why?
|
| Neoplasms | 12 | 2023 | 22340 | 0.300 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 2242 | 0.300 |
Why?
|
| Carotenoids | 4 | 2007 | 619 | 0.300 |
Why?
|
| Uterine Neoplasms | 4 | 2013 | 1421 | 0.290 |
Why?
|
| Melanoma | 7 | 2020 | 5719 | 0.280 |
Why?
|
| Male | 104 | 2024 | 363698 | 0.280 |
Why?
|
| Pancreatic Neoplasms | 7 | 2021 | 5444 | 0.280 |
Why?
|
| Maternal Exposure | 3 | 2019 | 1095 | 0.280 |
Why?
|
| DNA | 8 | 2022 | 7202 | 0.280 |
Why?
|
| Gene Dosage | 4 | 2016 | 1216 | 0.270 |
Why?
|
| Epigenomics | 3 | 2024 | 959 | 0.270 |
Why?
|
| Exercise | 3 | 2020 | 5937 | 0.270 |
Why?
|
| Nevus | 2 | 2020 | 205 | 0.270 |
Why?
|
| Odds Ratio | 18 | 2025 | 9649 | 0.270 |
Why?
|
| Nutritional Status | 3 | 2018 | 1620 | 0.270 |
Why?
|
| Isoenzymes | 3 | 2006 | 1689 | 0.270 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 1326 | 0.260 |
Why?
|
| Diet Records | 4 | 2016 | 425 | 0.260 |
Why?
|
| GATA5 Transcription Factor | 1 | 2006 | 18 | 0.260 |
Why?
|
| Receptors, Androgen | 4 | 2009 | 1088 | 0.260 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2006 | 82 | 0.260 |
Why?
|
| Vitamin B 12 | 2 | 2023 | 532 | 0.260 |
Why?
|
| Oxidative Stress | 10 | 2023 | 3141 | 0.250 |
Why?
|
| Models, Genetic | 6 | 2020 | 3449 | 0.250 |
Why?
|
| Research Design | 3 | 2022 | 6209 | 0.250 |
Why?
|
| Genes, p53 | 3 | 2007 | 711 | 0.250 |
Why?
|
| Mitochondria | 5 | 2023 | 3673 | 0.250 |
Why?
|
| Women's Health | 8 | 2019 | 2084 | 0.240 |
Why?
|
| Incidence | 15 | 2024 | 21480 | 0.240 |
Why?
|
| Multifactorial Inheritance | 4 | 2024 | 1425 | 0.230 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2005 | 187 | 0.230 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2007 | 2880 | 0.230 |
Why?
|
| Androgens | 2 | 2009 | 1279 | 0.230 |
Why?
|
| Stress Disorders, Post-Traumatic | 7 | 2018 | 4628 | 0.230 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2004 | 30 | 0.230 |
Why?
|
| United States | 41 | 2025 | 72903 | 0.230 |
Why?
|
| Longevity | 3 | 2021 | 1087 | 0.230 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2004 | 766 | 0.220 |
Why?
|
| Amino Acid Substitution | 3 | 2004 | 1740 | 0.220 |
Why?
|
| Insulin Resistance | 1 | 2018 | 3985 | 0.220 |
Why?
|
| Dietary Supplements | 3 | 2023 | 3425 | 0.220 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2022 | 1376 | 0.220 |
Why?
|
| Phenol | 1 | 2023 | 45 | 0.210 |
Why?
|
| Genetic Association Studies | 6 | 2016 | 2741 | 0.210 |
Why?
|
| Testosterone | 2 | 2012 | 2494 | 0.210 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2022 | 1396 | 0.210 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 1936 | 0.210 |
Why?
|
| Age Factors | 16 | 2025 | 18380 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 5 | 2018 | 4772 | 0.210 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2004 | 276 | 0.210 |
Why?
|
| Depression | 7 | 2020 | 8237 | 0.200 |
Why?
|
| Proportional Hazards Models | 9 | 2020 | 12509 | 0.200 |
Why?
|
| Petroleum | 1 | 2022 | 82 | 0.200 |
Why?
|
| Confidence Intervals | 7 | 2013 | 2910 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2019 | 1657 | 0.200 |
Why?
|
| Follow-Up Studies | 22 | 2023 | 39193 | 0.200 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2003 | 99 | 0.190 |
Why?
|
| Mosaicism | 2 | 2016 | 481 | 0.190 |
Why?
|
| DNA Damage | 4 | 2021 | 2457 | 0.190 |
Why?
|
| Phenols | 2 | 2023 | 522 | 0.190 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2022 | 1044 | 0.190 |
Why?
|
| PPAR gamma | 1 | 2004 | 483 | 0.190 |
Why?
|
| Germ-Line Mutation | 3 | 2017 | 1884 | 0.190 |
Why?
|
| Environment | 2 | 2023 | 1114 | 0.190 |
Why?
|
| Least-Squares Analysis | 2 | 2012 | 368 | 0.190 |
Why?
|
| Diet Surveys | 2 | 2016 | 1159 | 0.180 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2021 | 1404 | 0.180 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2446 | 0.180 |
Why?
|
| Anxiety Disorders | 1 | 2012 | 2737 | 0.180 |
Why?
|
| Insulin | 2 | 2020 | 6599 | 0.180 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2017 | 705 | 0.180 |
Why?
|
| Barrett Esophagus | 2 | 2019 | 494 | 0.180 |
Why?
|
| Risk Assessment | 14 | 2020 | 24282 | 0.180 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2003 | 335 | 0.180 |
Why?
|
| DNA Repair | 5 | 2021 | 2048 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2011 | 247 | 0.170 |
Why?
|
| Apolipoprotein E4 | 2 | 2024 | 708 | 0.170 |
Why?
|
| Urogenital Neoplasms | 1 | 2021 | 129 | 0.170 |
Why?
|
| Cognition | 4 | 2024 | 7049 | 0.170 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2002 | 423 | 0.160 |
Why?
|
| Mutation, Missense | 3 | 2009 | 2589 | 0.160 |
Why?
|
| Membrane Proteins | 6 | 2023 | 7851 | 0.160 |
Why?
|
| Osteosarcoma | 2 | 2023 | 909 | 0.160 |
Why?
|
| Triclosan | 1 | 2019 | 59 | 0.160 |
Why?
|
| Longitudinal Studies | 14 | 2023 | 14751 | 0.160 |
Why?
|
| Occupational Diseases | 4 | 2014 | 1456 | 0.160 |
Why?
|
| Cholecalciferol | 1 | 2024 | 550 | 0.160 |
Why?
|
| Ovary | 2 | 2021 | 956 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2000 | 416 | 0.160 |
Why?
|
| Occupational Exposure | 3 | 2021 | 1805 | 0.150 |
Why?
|
| Linkage Disequilibrium | 9 | 2016 | 1997 | 0.150 |
Why?
|
| Siblings | 2 | 2020 | 828 | 0.150 |
Why?
|
| Flavonols | 1 | 2018 | 85 | 0.150 |
Why?
|
| Astronauts | 1 | 2019 | 94 | 0.150 |
Why?
|
| Cholesterol, HDL | 3 | 2022 | 1811 | 0.150 |
Why?
|
| Vinyl Chloride | 2 | 1996 | 15 | 0.150 |
Why?
|
| Inflammation | 8 | 2023 | 10850 | 0.150 |
Why?
|
| DNA-Binding Proteins | 8 | 2014 | 9601 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 8611 | 0.140 |
Why?
|
| Colorectal Neoplasms | 4 | 2022 | 6942 | 0.140 |
Why?
|
| Receptors, Adiponectin | 1 | 2018 | 82 | 0.140 |
Why?
|
| Mammals | 1 | 2023 | 1125 | 0.140 |
Why?
|
| Cell Survival | 2 | 2023 | 5747 | 0.140 |
Why?
|
| Folic Acid | 4 | 2013 | 1338 | 0.140 |
Why?
|
| Cacao | 1 | 2018 | 98 | 0.140 |
Why?
|
| Aged, 80 and over | 19 | 2024 | 59489 | 0.140 |
Why?
|
| Estrogens | 4 | 2015 | 1529 | 0.140 |
Why?
|
| Ribonucleoproteins | 2 | 2017 | 359 | 0.140 |
Why?
|
| Particulate Matter | 4 | 2018 | 2624 | 0.140 |
Why?
|
| Prognosis | 14 | 2020 | 29922 | 0.140 |
Why?
|
| Cooking | 2 | 2022 | 327 | 0.140 |
Why?
|
| Health Surveys | 6 | 2020 | 4056 | 0.140 |
Why?
|
| Stress, Psychological | 4 | 2024 | 4533 | 0.140 |
Why?
|
| Smoke | 1 | 2019 | 243 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2010 | 348 | 0.140 |
Why?
|
| Arachidonic Acid | 1 | 2018 | 430 | 0.140 |
Why?
|
| Apoptosis | 4 | 2009 | 9514 | 0.130 |
Why?
|
| Endocrine Disruptors | 1 | 2019 | 249 | 0.130 |
Why?
|
| Life Expectancy | 1 | 2023 | 1247 | 0.130 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2016 | 68 | 0.130 |
Why?
|
| Residence Characteristics | 3 | 2023 | 2116 | 0.130 |
Why?
|
| Space Flight | 1 | 2019 | 219 | 0.130 |
Why?
|
| Receptors, Leptin | 1 | 2018 | 355 | 0.130 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.130 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2000 | 587 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 3247 | 0.130 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 4040 | 0.130 |
Why?
|
| DNA, Neoplasm | 5 | 2012 | 1742 | 0.130 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2015 | 22 | 0.130 |
Why?
|
| Disease-Free Survival | 4 | 2021 | 6832 | 0.130 |
Why?
|
| Anesthetics, Inhalation | 1 | 2021 | 573 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1061 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2021 | 12240 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 127 | 0.120 |
Why?
|
| Fertilization in Vitro | 1 | 2003 | 1306 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2014 | 386 | 0.120 |
Why?
|
| Population Groups | 1 | 2016 | 209 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2016 | 191 | 0.120 |
Why?
|
| Homocysteine | 1 | 2018 | 638 | 0.120 |
Why?
|
| ROC Curve | 1 | 2023 | 3620 | 0.120 |
Why?
|
| Birth Weight | 1 | 2023 | 2121 | 0.120 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 9525 | 0.120 |
Why?
|
| Depressive Disorder, Major | 4 | 2018 | 4808 | 0.120 |
Why?
|
| Air Pollution, Indoor | 1 | 2022 | 931 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2016 | 371 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 2 | 2017 | 578 | 0.120 |
Why?
|
| Phthalic Acids | 1 | 2019 | 484 | 0.120 |
Why?
|
| Memory | 1 | 2024 | 2190 | 0.120 |
Why?
|
| Carcinogens | 2 | 2012 | 452 | 0.120 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 565 | 0.110 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 171 | 0.110 |
Why?
|
| Genome, Human | 3 | 2015 | 4448 | 0.110 |
Why?
|
| Menstrual Cycle | 2 | 2015 | 540 | 0.110 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 2393 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2011 | 1151 | 0.110 |
Why?
|
| Phenotype | 9 | 2020 | 16721 | 0.110 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2014 | 52 | 0.110 |
Why?
|
| Pilot Projects | 5 | 2023 | 8733 | 0.110 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 319 | 0.110 |
Why?
|
| Cyclin E | 1 | 2014 | 156 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2016 | 4044 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2020 | 1885 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2022 | 3785 | 0.110 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2014 | 34 | 0.110 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 229 | 0.110 |
Why?
|
| Caregivers | 2 | 2018 | 2307 | 0.110 |
Why?
|
| Apolipoproteins E | 3 | 2024 | 1458 | 0.110 |
Why?
|
| Triglycerides | 2 | 2020 | 2441 | 0.110 |
Why?
|
| Receptor, Insulin | 1 | 2018 | 837 | 0.110 |
Why?
|
| Body Fat Distribution | 1 | 2015 | 246 | 0.110 |
Why?
|
| Work Schedule Tolerance | 2 | 2023 | 555 | 0.110 |
Why?
|
| Transplantation Conditioning | 1 | 2020 | 1635 | 0.110 |
Why?
|
| Casein Kinase II | 1 | 2014 | 120 | 0.110 |
Why?
|
| Genes, ras | 3 | 2008 | 658 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 939 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 93 | 0.110 |
Why?
|
| Health Behavior | 2 | 2016 | 2650 | 0.110 |
Why?
|
| Gallstones | 1 | 2016 | 285 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2014 | 350 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15398 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1857 | 0.110 |
Why?
|
| Europe | 6 | 2021 | 3423 | 0.110 |
Why?
|
| Welding | 1 | 2014 | 89 | 0.110 |
Why?
|
| Saliva | 2 | 2015 | 851 | 0.110 |
Why?
|
| Antigens, CD | 2 | 2018 | 4025 | 0.100 |
Why?
|
| Dementia | 1 | 2008 | 2744 | 0.100 |
Why?
|
| Adolescent | 19 | 2024 | 88835 | 0.100 |
Why?
|
| Epidemiologic Studies | 4 | 2018 | 677 | 0.100 |
Why?
|
| Intrauterine Devices | 1 | 2014 | 115 | 0.100 |
Why?
|
| Mutagens | 1 | 2014 | 179 | 0.100 |
Why?
|
| Polycyclic Compounds | 1 | 1992 | 28 | 0.100 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2013 | 55 | 0.100 |
Why?
|
| Love | 1 | 2013 | 40 | 0.100 |
Why?
|
| Hemangiosarcoma | 2 | 1996 | 211 | 0.100 |
Why?
|
| Intestinal Polyps | 1 | 1993 | 105 | 0.100 |
Why?
|
| Anemia, Aplastic | 1 | 2015 | 232 | 0.100 |
Why?
|
| Genetic Markers | 4 | 2023 | 2601 | 0.100 |
Why?
|
| Critical Pathways | 1 | 2016 | 474 | 0.100 |
Why?
|
| Carcinogens, Environmental | 1 | 1992 | 70 | 0.100 |
Why?
|
| Cause of Death | 3 | 2020 | 3708 | 0.100 |
Why?
|
| Child Abuse, Sexual | 1 | 2015 | 397 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 1602 | 0.100 |
Why?
|
| Disabled Children | 1 | 2014 | 250 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 1308 | 0.100 |
Why?
|
| Child Development | 2 | 2023 | 2327 | 0.100 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2013 | 129 | 0.100 |
Why?
|
| Genomic Instability | 2 | 2019 | 718 | 0.100 |
Why?
|
| Nepal | 2 | 2023 | 301 | 0.100 |
Why?
|
| Adiponectin | 1 | 2018 | 1119 | 0.100 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 8730 | 0.100 |
Why?
|
| Genomic Imprinting | 3 | 2017 | 326 | 0.100 |
Why?
|
| Cell Division | 2 | 1998 | 4475 | 0.090 |
Why?
|
| Vitamin B 6 | 1 | 2013 | 238 | 0.090 |
Why?
|
| Spinal Cord Injuries | 1 | 2019 | 927 | 0.090 |
Why?
|
| Prostatic Neoplasms | 4 | 2023 | 11083 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2014 | 4520 | 0.090 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2011 | 22 | 0.090 |
Why?
|
| Occupations | 1 | 2014 | 516 | 0.090 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2011 | 53 | 0.090 |
Why?
|
| Socioeconomic Factors | 6 | 2024 | 7838 | 0.090 |
Why?
|
| Sex Factors | 4 | 2020 | 10603 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2023 | 10429 | 0.090 |
Why?
|
| Chromosome Aberrations | 2 | 2015 | 1774 | 0.090 |
Why?
|
| Depressive Disorder | 3 | 2019 | 3714 | 0.090 |
Why?
|
| Premenopause | 3 | 2008 | 1037 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 3596 | 0.090 |
Why?
|
| Infant, Premature | 1 | 2021 | 2122 | 0.090 |
Why?
|
| Choline | 1 | 2013 | 510 | 0.090 |
Why?
|
| Inhalation Exposure | 1 | 2014 | 432 | 0.090 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2010 | 30 | 0.090 |
Why?
|
| Receptors, Calcitriol | 1 | 2013 | 361 | 0.090 |
Why?
|
| Leukocyte Count | 1 | 2014 | 1602 | 0.090 |
Why?
|
| Psychosocial Deprivation | 1 | 2011 | 101 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 710 | 0.090 |
Why?
|
| Methionine | 1 | 2013 | 569 | 0.090 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2013 | 272 | 0.090 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2011 | 132 | 0.090 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2010 | 95 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 4 | 2015 | 3602 | 0.090 |
Why?
|
| Gene Expression | 2 | 2021 | 7584 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2015 | 993 | 0.090 |
Why?
|
| Environmental Pollutants | 1 | 2019 | 1290 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 703 | 0.090 |
Why?
|
| Young Adult | 15 | 2025 | 59889 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 2796 | 0.080 |
Why?
|
| Cognition Disorders | 3 | 2011 | 3967 | 0.080 |
Why?
|
| Child, Institutionalized | 1 | 2011 | 111 | 0.080 |
Why?
|
| Meditation | 1 | 2013 | 256 | 0.080 |
Why?
|
| Anesthesia | 1 | 2021 | 1590 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.080 |
Why?
|
| Probability | 2 | 2021 | 2475 | 0.080 |
Why?
|
| Quantitative Trait Loci | 4 | 2020 | 2140 | 0.080 |
Why?
|
| Reference Values | 3 | 2007 | 4908 | 0.080 |
Why?
|
| Maternal Age | 1 | 2012 | 804 | 0.080 |
Why?
|
| Linear Models | 3 | 2017 | 5876 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 2016 | 943 | 0.080 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2016 | 742 | 0.080 |
Why?
|
| Lung Neoplasms | 8 | 2020 | 13451 | 0.080 |
Why?
|
| BRCA1 Protein | 1 | 2015 | 1153 | 0.080 |
Why?
|
| Nails | 2 | 2014 | 298 | 0.080 |
Why?
|
| Breast Feeding | 1 | 2017 | 1364 | 0.080 |
Why?
|
| Resilience, Psychological | 1 | 2016 | 806 | 0.080 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2008 | 5 | 0.080 |
Why?
|
| Codon | 2 | 2004 | 595 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1624 | 0.080 |
Why?
|
| Parturition | 1 | 2012 | 454 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 1998 | 4913 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 372 | 0.080 |
Why?
|
| Anthropometry | 2 | 2016 | 1338 | 0.080 |
Why?
|
| Rhodopsin | 1 | 2009 | 202 | 0.080 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 20124 | 0.080 |
Why?
|
| Infant | 9 | 2023 | 36386 | 0.070 |
Why?
|
| Perception | 1 | 2014 | 1205 | 0.070 |
Why?
|
| Child | 14 | 2024 | 80564 | 0.070 |
Why?
|
| HLA-DR Antigens | 1 | 2010 | 608 | 0.070 |
Why?
|
| Hormones | 2 | 2003 | 863 | 0.070 |
Why?
|
| Adiposity | 1 | 2018 | 1890 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2008 | 64 | 0.070 |
Why?
|
| Colonic Polyps | 1 | 1993 | 556 | 0.070 |
Why?
|
| Calcium | 2 | 2013 | 5767 | 0.070 |
Why?
|
| Contraceptives, Oral | 2 | 2025 | 559 | 0.070 |
Why?
|
| Base Sequence | 4 | 2009 | 12403 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2009 | 533 | 0.070 |
Why?
|
| Hydrolases | 1 | 2008 | 146 | 0.070 |
Why?
|
| Parents | 3 | 2020 | 3592 | 0.070 |
Why?
|
| Carcinoma in Situ | 1 | 2013 | 779 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 381 | 0.070 |
Why?
|
| Disease Susceptibility | 2 | 2004 | 1789 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2226 | 0.070 |
Why?
|
| Prolactin | 1 | 2009 | 625 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2008 | 292 | 0.070 |
Why?
|
| Metabolomics | 1 | 2016 | 1668 | 0.070 |
Why?
|
| Neoplasm Staging | 5 | 2013 | 11206 | 0.070 |
Why?
|
| Ethanol | 1 | 2013 | 1323 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 4 | 2006 | 5786 | 0.070 |
Why?
|
| Parity | 2 | 2025 | 931 | 0.070 |
Why?
|
| Venous Thromboembolism | 2 | 2017 | 1882 | 0.070 |
Why?
|
| Alanine | 2 | 2009 | 612 | 0.070 |
Why?
|
| Environmental Exposure | 2 | 2019 | 4544 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1994 | 1761 | 0.060 |
Why?
|
| CpG Islands | 2 | 2022 | 1207 | 0.060 |
Why?
|
| Child, Preschool | 8 | 2023 | 42500 | 0.060 |
Why?
|
| NFATC Transcription Factors | 1 | 2008 | 392 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 1028 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2014 | 3401 | 0.060 |
Why?
|
| Regression Analysis | 3 | 2014 | 6322 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2008 | 720 | 0.060 |
Why?
|
| Retinitis Pigmentosa | 1 | 2009 | 394 | 0.060 |
Why?
|
| Sex Characteristics | 4 | 2024 | 2643 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2015 | 2395 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 1998 | 4778 | 0.060 |
Why?
|
| Animals | 12 | 2024 | 168764 | 0.060 |
Why?
|
| Self Report | 2 | 2018 | 3770 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 3 | 2014 | 1370 | 0.060 |
Why?
|
| Body Size | 1 | 2007 | 459 | 0.060 |
Why?
|
| Androstenedione | 1 | 2004 | 138 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2010 | 1329 | 0.060 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 654 | 0.060 |
Why?
|
| Air Pollution | 1 | 2018 | 2380 | 0.060 |
Why?
|
| Survival Rate | 4 | 2021 | 12795 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 1927 | 0.060 |
Why?
|
| Flavonoids | 1 | 2007 | 448 | 0.060 |
Why?
|
| Estrogens, Catechol | 1 | 2004 | 25 | 0.060 |
Why?
|
| Air Pollutants | 1 | 2018 | 2923 | 0.060 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2008 | 488 | 0.060 |
Why?
|
| Trinucleotide Repeats | 1 | 2005 | 258 | 0.060 |
Why?
|
| Glucuronides | 1 | 2004 | 20 | 0.060 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2006 | 291 | 0.060 |
Why?
|
| Hypertension | 1 | 2024 | 8626 | 0.060 |
Why?
|
| Rectal Neoplasms | 1 | 1993 | 1182 | 0.060 |
Why?
|
| Proteins | 3 | 2014 | 5995 | 0.060 |
Why?
|
| Ketone Bodies | 1 | 2023 | 75 | 0.050 |
Why?
|
| Lung | 3 | 2022 | 10033 | 0.050 |
Why?
|
| RNA | 1 | 2013 | 2717 | 0.050 |
Why?
|
| Puberty, Delayed | 1 | 2024 | 124 | 0.050 |
Why?
|
| Genomics | 2 | 2016 | 5929 | 0.050 |
Why?
|
| Anxiety | 1 | 2018 | 4671 | 0.050 |
Why?
|
| Hypertriglyceridemia | 1 | 2006 | 290 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2007 | 547 | 0.050 |
Why?
|
| Leucine | 1 | 2004 | 546 | 0.050 |
Why?
|
| Pregnancy | 7 | 2020 | 30260 | 0.050 |
Why?
|
| Mutation | 6 | 2017 | 30198 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2019 | 10383 | 0.050 |
Why?
|
| Neuropsychological Tests | 3 | 2024 | 7123 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2011 | 2844 | 0.050 |
Why?
|
| Puberty, Precocious | 1 | 2024 | 163 | 0.050 |
Why?
|
| Valine | 1 | 2004 | 410 | 0.050 |
Why?
|
| Organ Size | 1 | 2008 | 2260 | 0.050 |
Why?
|
| Selenium | 1 | 2005 | 419 | 0.050 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2023 | 119 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2023 | 12437 | 0.050 |
Why?
|
| Infant, Newborn | 5 | 2021 | 26346 | 0.050 |
Why?
|
| Health Resources | 1 | 2009 | 949 | 0.050 |
Why?
|
| Australia | 3 | 2012 | 1258 | 0.050 |
Why?
|
| Poland | 2 | 2012 | 195 | 0.050 |
Why?
|
| Adenoma | 1 | 1993 | 2152 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2002 | 125 | 0.050 |
Why?
|
| beta Carotene | 1 | 2003 | 522 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2008 | 17075 | 0.050 |
Why?
|
| Fertility | 2 | 2021 | 768 | 0.050 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 15652 | 0.050 |
Why?
|
| Sleep | 2 | 2023 | 4813 | 0.050 |
Why?
|
| Massachusetts | 5 | 2015 | 8875 | 0.050 |
Why?
|
| Educational Status | 2 | 2024 | 2513 | 0.050 |
Why?
|
| Motor Activity | 1 | 2012 | 2704 | 0.050 |
Why?
|
| Age Distribution | 1 | 2007 | 2858 | 0.050 |
Why?
|
| Liver Neoplasms | 2 | 1996 | 4353 | 0.050 |
Why?
|
| Sarcoma | 1 | 2013 | 1802 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 2003 | 271 | 0.050 |
Why?
|
| Personality Inventory | 1 | 2004 | 1018 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2844 | 0.050 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2022 | 226 | 0.050 |
Why?
|
| Ultraviolet Rays | 2 | 2016 | 1102 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 12056 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4562 | 0.050 |
Why?
|
| Epithelial Cells | 2 | 2010 | 3681 | 0.050 |
Why?
|
| Endometrium | 1 | 2004 | 406 | 0.050 |
Why?
|
| Survival Analysis | 3 | 2020 | 10070 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 1077 | 0.050 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2021 | 104 | 0.040 |
Why?
|
| Hospitalization | 1 | 2021 | 10808 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 114 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2010 | 1348 | 0.040 |
Why?
|
| Fetal Blood | 2 | 2018 | 1369 | 0.040 |
Why?
|
| Endophenotypes | 1 | 2022 | 258 | 0.040 |
Why?
|
| Mouth Mucosa | 1 | 2003 | 432 | 0.040 |
Why?
|
| Molecular Sequence Data | 5 | 2009 | 17594 | 0.040 |
Why?
|
| China | 3 | 2012 | 2385 | 0.040 |
Why?
|
| Nitrous Oxide | 1 | 2021 | 166 | 0.040 |
Why?
|
| Menopause, Premature | 1 | 2021 | 124 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2018 | 23601 | 0.040 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 325 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2010 | 2590 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 4058 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2004 | 1752 | 0.040 |
Why?
|
| Epidemiologic Research Design | 1 | 2003 | 368 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2013 | 3000 | 0.040 |
Why?
|
| Social Justice | 1 | 2024 | 485 | 0.040 |
Why?
|
| Chi-Square Distribution | 3 | 2014 | 3432 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2022 | 3797 | 0.040 |
Why?
|
| United States National Aeronautics and Space Administration | 1 | 2019 | 16 | 0.040 |
Why?
|
| Vitamins | 2 | 2005 | 1630 | 0.040 |
Why?
|
| Wheelchairs | 1 | 2019 | 78 | 0.040 |
Why?
|
| Binding Sites | 2 | 2006 | 6001 | 0.040 |
Why?
|
| Melphalan | 1 | 2020 | 425 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2019 | 6853 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 852 | 0.040 |
Why?
|
| Nitrosamines | 1 | 2019 | 85 | 0.040 |
Why?
|
| Flavanones | 1 | 2019 | 75 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2023 | 633 | 0.040 |
Why?
|
| Urinary Bladder Diseases | 1 | 2019 | 166 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 647 | 0.040 |
Why?
|
| Glioma | 1 | 2013 | 3493 | 0.040 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 1741 | 0.040 |
Why?
|
| Oxidants | 1 | 2019 | 166 | 0.040 |
Why?
|
| Air Pollutants, Occupational | 1 | 2021 | 406 | 0.040 |
Why?
|
| Women | 1 | 2020 | 226 | 0.040 |
Why?
|
| Catechin | 1 | 2018 | 69 | 0.040 |
Why?
|
| Fruit | 2 | 2019 | 1166 | 0.040 |
Why?
|
| Vegetables | 2 | 2019 | 1199 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2012 | 4618 | 0.040 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2017 | 16 | 0.040 |
Why?
|
| Spain | 2 | 2010 | 483 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2000 | 784 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 1066 | 0.040 |
Why?
|
| South Africa | 1 | 2023 | 1867 | 0.040 |
Why?
|
| Ketones | 1 | 2019 | 183 | 0.040 |
Why?
|
| Placenta | 2 | 2017 | 1728 | 0.040 |
Why?
|
| Isoflurane | 1 | 2021 | 384 | 0.040 |
Why?
|
| Bone Neoplasms | 2 | 2023 | 2567 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2020 | 304 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 2531 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10729 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 661 | 0.040 |
Why?
|
| Fasting | 1 | 2023 | 1606 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2268 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2019 | 9347 | 0.030 |
Why?
|
| Dopamine | 1 | 2004 | 1582 | 0.030 |
Why?
|
| Urinary Bladder | 2 | 2014 | 1154 | 0.030 |
Why?
|
| New Hampshire | 2 | 2008 | 174 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2005 | 2354 | 0.030 |
Why?
|
| Cotinine | 1 | 2017 | 206 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 1242 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5753 | 0.030 |
Why?
|
| Personality Assessment | 1 | 2018 | 646 | 0.030 |
Why?
|
| SEER Program | 1 | 2021 | 1446 | 0.030 |
Why?
|
| Heterozygote | 3 | 2009 | 2794 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2017 | 1892 | 0.030 |
Why?
|
| Genetic Drift | 1 | 2016 | 41 | 0.030 |
Why?
|
| Registries | 3 | 2023 | 8297 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2008 | 88 | 0.030 |
Why?
|
| Molecular Epidemiology | 2 | 1996 | 471 | 0.030 |
Why?
|
| Death Certificates | 1 | 2016 | 170 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1998 | 457 | 0.030 |
Why?
|
| Psychology | 1 | 2018 | 354 | 0.030 |
Why?
|
| Retroviridae | 1 | 1998 | 847 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2002 | 2352 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2003 | 2002 | 0.030 |
Why?
|
| Mice | 6 | 2024 | 81819 | 0.030 |
Why?
|
| Causality | 1 | 2022 | 1248 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 1998 | 898 | 0.030 |
Why?
|
| Aspirin | 1 | 2007 | 3134 | 0.030 |
Why?
|
| Mobility Limitation | 1 | 2019 | 408 | 0.030 |
Why?
|
| Interleukin-1beta | 2 | 2014 | 1028 | 0.030 |
Why?
|
| Hippocampus | 1 | 2008 | 3775 | 0.030 |
Why?
|
| Prejudice | 1 | 2019 | 567 | 0.030 |
Why?
|
| Health Occupations | 1 | 2016 | 226 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1806 | 0.030 |
Why?
|
| Feeding Behavior | 2 | 2019 | 3212 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2019 | 929 | 0.030 |
Why?
|
| Karyotyping | 1 | 2016 | 1178 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 59 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2016 | 353 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2012 | 1718 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 841 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2000 | 1119 | 0.030 |
Why?
|
| Exons | 1 | 2000 | 2391 | 0.030 |
Why?
|
| Homozygote | 2 | 2009 | 1775 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 56 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 734 | 0.030 |
Why?
|
| Chile | 1 | 2014 | 258 | 0.030 |
Why?
|
| Labor Unions | 1 | 2014 | 50 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2019 | 1339 | 0.030 |
Why?
|
| Nicotine | 1 | 2019 | 682 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2004 | 2224 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2015 | 520 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 545 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 14652 | 0.030 |
Why?
|
| Prevalence | 3 | 2017 | 15842 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 855 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2008 | 2895 | 0.030 |
Why?
|
| Data Collection | 1 | 2023 | 3318 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 229 | 0.030 |
Why?
|
| Alu Elements | 1 | 2014 | 115 | 0.030 |
Why?
|
| Protein Binding | 3 | 2006 | 9296 | 0.030 |
Why?
|
| Air | 1 | 2014 | 181 | 0.030 |
Why?
|
| Carcinoma | 1 | 2004 | 2312 | 0.030 |
Why?
|
| Weight Gain | 1 | 2023 | 2355 | 0.030 |
Why?
|
| Sister Chromatid Exchange | 1 | 1992 | 60 | 0.030 |
Why?
|
| Pigmentation | 1 | 2013 | 143 | 0.030 |
Why?
|
| Genetic Pleiotropy | 1 | 2014 | 182 | 0.030 |
Why?
|
| Michigan | 1 | 2013 | 328 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2003 | 99 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 1994 | 2942 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 2900 | 0.030 |
Why?
|
| Metals, Heavy | 1 | 2014 | 151 | 0.030 |
Why?
|
| Phylogeny | 1 | 2000 | 2832 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6113 | 0.020 |
Why?
|
| Algorithms | 2 | 2020 | 14071 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1994 | 341 | 0.020 |
Why?
|
| tau Proteins | 1 | 2022 | 2112 | 0.020 |
Why?
|
| Cholesterol | 2 | 2016 | 2898 | 0.020 |
Why?
|
| Marital Status | 1 | 2013 | 426 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2014 | 332 | 0.020 |
Why?
|
| Time Factors | 4 | 2019 | 40065 | 0.020 |
Why?
|
| Weight Loss | 1 | 2023 | 2710 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2014 | 354 | 0.020 |
Why?
|
| Diabetes Mellitus | 2 | 2025 | 5891 | 0.020 |
Why?
|
| Sunlight | 1 | 2013 | 337 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2005 | 6255 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2015 | 932 | 0.020 |
Why?
|
| Overweight | 1 | 2022 | 2444 | 0.020 |
Why?
|
| Telomeric Repeat Binding Protein 1 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Hair Color | 1 | 2011 | 132 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2008 | 5389 | 0.020 |
Why?
|
| Contraception | 1 | 2014 | 361 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2021 | 2554 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2014 | 700 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 9747 | 0.020 |
Why?
|
| Religion | 1 | 2014 | 376 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 1123 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1751 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 697 | 0.020 |
Why?
|
| Foster Home Care | 1 | 2011 | 140 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4526 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 2966 | 0.020 |
Why?
|
| Selection Bias | 1 | 2011 | 361 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 786 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 6220 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3584 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 3896 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2009 | 56 | 0.020 |
Why?
|
| Finland | 1 | 2010 | 608 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2008 | 68 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2003 | 12131 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 735 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2034 | 0.020 |
Why?
|
| Gestational Age | 1 | 2017 | 3609 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3067 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2014 | 1183 | 0.020 |
Why?
|
| Body Weight | 1 | 2019 | 4622 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1994 | 995 | 0.020 |
Why?
|
| Comorbidity | 1 | 2023 | 10563 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2010 | 345 | 0.020 |
Why?
|
| Microdissection | 1 | 2008 | 152 | 0.020 |
Why?
|
| Camptothecin | 1 | 2012 | 600 | 0.020 |
Why?
|
| Sample Size | 1 | 2011 | 845 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 1628 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2010 | 955 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2010 | 780 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2008 | 214 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11022 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 5077 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 1589 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2021 | 3461 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1892 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2009 | 220 | 0.020 |
Why?
|
| India | 1 | 2014 | 2334 | 0.020 |
Why?
|
| Hospitals | 1 | 2021 | 3888 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2009 | 299 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2009 | 203 | 0.020 |
Why?
|
| Lipids | 1 | 2018 | 3315 | 0.020 |
Why?
|
| Liver | 2 | 2012 | 7562 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 1994 | 976 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2014 | 1896 | 0.020 |
Why?
|
| Electroretinography | 1 | 2009 | 526 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1748 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2010 | 538 | 0.020 |
Why?
|
| Seasons | 1 | 1992 | 1524 | 0.020 |
Why?
|
| Chromatin | 1 | 2018 | 2980 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2010 | 81514 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2009 | 856 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 4860 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 1992 | 1470 | 0.020 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 332 | 0.020 |
Why?
|
| Glycine | 1 | 2009 | 672 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 130 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6203 | 0.020 |
Why?
|
| Public Health Nursing | 1 | 2005 | 14 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1434 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2015 | 5089 | 0.020 |
Why?
|
| Veterans | 1 | 2018 | 2664 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 2014 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6499 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1646 | 0.010 |
Why?
|
| Lasers | 1 | 2008 | 951 | 0.010 |
Why?
|
| Fats, Unsaturated | 1 | 2003 | 21 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2660 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3222 | 0.010 |
Why?
|
| DNA Ligases | 1 | 2003 | 81 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 1130 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2009 | 1441 | 0.010 |
Why?
|
| Epitopes | 1 | 2010 | 2523 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2003 | 45 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2686 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2008 | 2630 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8278 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22332 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3513 | 0.010 |
Why?
|
| Violence | 1 | 2009 | 935 | 0.010 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2002 | 27 | 0.010 |
Why?
|
| Verbal Learning | 1 | 2005 | 461 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1998 | 18973 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1994 | 3807 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2975 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 4348 | 0.010 |
Why?
|
| International Cooperation | 1 | 2009 | 1432 | 0.010 |
Why?
|
| Computational Biology | 1 | 2014 | 3559 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3850 | 0.010 |
Why?
|
| Proline | 1 | 2003 | 453 | 0.010 |
Why?
|
| TATA Box | 1 | 2001 | 127 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15880 | 0.010 |
Why?
|
| Body Composition | 1 | 2010 | 2439 | 0.010 |
Why?
|
| Methyltransferases | 1 | 2003 | 371 | 0.010 |
Why?
|
| Family | 1 | 2010 | 3209 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 7599 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13632 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20659 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 6014 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 4274 | 0.010 |
Why?
|
| Memory, Short-Term | 1 | 2005 | 1003 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2014 | 3413 | 0.010 |
Why?
|
| Quality of Life | 1 | 2019 | 13462 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 1998 | 69 | 0.010 |
Why?
|
| Histone Chaperones | 1 | 1998 | 82 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 966 | 0.010 |
Why?
|
| Brain | 1 | 2024 | 27171 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2013 | 8067 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 36532 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12768 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 65188 | 0.010 |
Why?
|
| Internet | 1 | 2009 | 3106 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1998 | 1081 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 1744 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 4416 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1998 | 1160 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1992 | 11888 | 0.010 |
Why?
|
| France | 1 | 1996 | 495 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2006 | 3312 | 0.010 |
Why?
|
| Asbestosis | 1 | 1994 | 81 | 0.010 |
Why?
|
| Silicosis | 1 | 1994 | 47 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1998 | 13400 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 1995 | 324 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2745 | 0.010 |
Why?
|
| Health Personnel | 1 | 2007 | 3390 | 0.010 |
Why?
|
| Mass Screening | 1 | 2009 | 5446 | 0.010 |
Why?
|
| Receptor, erbB-2 | 2 | 1994 | 2593 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1998 | 722 | 0.010 |
Why?
|
| Growth Substances | 1 | 1995 | 758 | 0.010 |
Why?
|
| Asbestos | 1 | 1994 | 250 | 0.010 |
Why?
|
| Mammography | 1 | 2003 | 2423 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 1994 | 420 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 1998 | 3750 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1994 | 1644 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 945 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1992 | 1210 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1994 | 1083 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1994 | 2887 | 0.000 |
Why?
|
| Myocardium | 1 | 1998 | 4760 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1992 | 3946 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1996 | 2329 | 0.000 |
Why?
|
| Peptides | 1 | 1992 | 4331 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1998 | 11641 | 0.000 |
Why?
|